ArticleOrphanet journal of rare diseases2026
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a relapsing polychondritis disease-specific quality of life instrument (ERN ReCONNET RP-QoL).Rheumatology (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
introductionRelapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation of cartilaginous structures and a broad spectrum of systemic features. To date, no Health-related Quality of life (QoL) data are available in RP, and generic measures may not fully capture the unique burden faced by patients, given the specific nature of RP symptoms. This study aimed to identify QoL facets relevant for further inclusion in a disease-specific QoL instrument, the RP-QoL.
methodsAn international study was conducted within the framework of the European Reference Network ReCONNET, using an online interview script designed by nine physicians, a clinical psychologist, and two patient representatives. The survey was cross-culturally adapted into five languages. Thematic analysis was performed by native speakers of each language and further aggregated to characterize QoL in RP.
resultsA total of 274 patients (median age: 54yo, 86% women) from 22 countries completed the interview. The most affected QoL facets were ‘personal relationships’ (58.8%), ‘work capacity’ (51.8%), and ‘daily activities’ (47.8%). Additional concerns included mainly fatigue, pain, cognition, mental health and social life. A total of 67 patients (24.5%) identified 20 specific issues not fully captured by generic QoL instruments, such as difficulties for planning, verbal communication, vision impairment, as well as not being considered seriously by those around them.
conclusionThis study highlights the profound burden of RP and emphasizes the need for the development of a disease-specific health-related QoL instrument, as a way to improve patient-centered care and disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.